Pharma Two B is a clinical-stage pharmaceutical company developing novel, synergistic, combination products based on previously approved drugs. We refined our years of expertise to identify and characterize potential drug combinations that can offer high therapeutic effects with improved safety profiles. Our goal is to develop clinically meaningful and safe added-value combination products to address unmet medical needs. Our lead investigational product, P2B001, successfully completed both Phase IIb and Phase III studies for the treatment for early Parkinson’s Disease (PD).